GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (FRA:ZOE) » Definitions » Common Stock

Zoetis (FRA:ZOE) Common Stock : €5 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Zoetis Common Stock?

Zoetis's quarterly common stock declined from Jun. 2024 (€5 Mil) to Sep. 2024 (€5 Mil) but then increased from Sep. 2024 (€5 Mil) to Dec. 2024 (€5 Mil).

Zoetis's annual common stock declined from Dec. 2022 (€5 Mil) to Dec. 2023 (€5 Mil) but then increased from Dec. 2023 (€5 Mil) to Dec. 2024 (€5 Mil).


Zoetis Common Stock Historical Data

The historical data trend for Zoetis's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Common Stock Chart

Zoetis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.11 4.43 4.72 4.59 4.78

Zoetis Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.59 4.60 4.65 4.51 4.78

Zoetis Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Zoetis Business Description

Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis Headlines

No Headlines